Tianxing Instrument held a media briefing on Wednesday afternoon on a major asset reorganization. The panoramic network broadcasted the live broadcast of the Tianxing Instrument Media Briefing. Berry Hekang’s Board of Directors and Chief Financial Officer Wang Dong introduced the media briefing session. Berry and Kang Hehua Compared with large genes, the characteristics are quite clear. First of all, Huada has a long line of business, basic scientific research, agriculture, and medical fields, including the national gene bank and a long line of business. In contrast, the characteristics of Berry and Kang are more distinct, focusing on medical applications, in which all research and development capabilities are concentrated to create a medical application platform, and various testing projects are continuously added to the platform. Berry Hekang is one of the few companies that can provide medical products and services to medical institutions at all levels of hospitals, third-party medical laboratories, etc., especially in the NIPT field. Basically, Berry and Kanghe Huada are comparative. Leading companies, Berry and Kang have a relatively high industry position in this field. Other friends, including Daan Gene, Daan Gene specifically took out that piece of business out of the third board, called Darry Bio. There is also Dean Diagnostics, Boao Bio, Annoyouda, and there is also a professional gene sequencing under Lepu Medical in Beijing. It is also listed on the third board. Berry and Kang are among the top market players in the field of reproductive health, especially the largest NIPT market segment.
Previously, Tianxing Instrument announced on December 4 that it intends to purchase 100% equity of Berry and Kang through the non-public issuance of A shares to all shareholders of Berry and Kang. After the transaction is completed, the listed company will hold Berry and Kang 100% equity, the transaction price of the proposed purchase of assets is 430,000 yuan, the stock issuance price of the shares purchased this time is 21.14 yuan / share, the total number of issued is 203,405,865 shares.
Swabs are ideal for collecting large numbers of samples and quickly eluting samples. It immediately releases specimens into transport media and is widely used in molecular genetics, forensic science, clinical laboratories, and more.
Sponge Swab,Medical disposable sample collection sample flocking swab,A tube flocking swab for the collection of nasal cell samples,Single use
Jiangsu iiLO Biotechnology Co., Ltd. , https://www.sjiilogene.com